NCT03076515 - Migraine Treatment With Nerivio Migra Neurostimulation Device | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

April 2, 2017

Primary Completion Date

January 31, 2018

Study Completion Date

April 1, 2018

Conditions

Acute Migraine

Interventions

DEVICE

Nerivio Migra neurostimulation

transcutaneous electrical stimulation

DEVICE

Sham Nerivio Migra

electrical stimulation- shame mode

Trial Locations (8)

Northwell Health, Inc, New York

Albany Medical College, Albany

MedStar - Georgetown University Hospital, Washington D.C.

Hartford Healthcare Headache Center, Hartford

Hillel Yaffe Medical Center, Hadera

Herzeliya medical Center, Herzliya

Maccabi Healthcare neurology clinics, Kfar Saba

Western Galilee Medical Center, Nahariya